Entity Central Index Key
Cover [Abstract]
Document Type
Document Type
Amendment Flag
Amendment Flag
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Trading Symbol
Trading Symbol
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Current Reporting Status
Entity Current Reporting Status
Entity Filer Category
Entity Filer Category
Entity Small Business
Entity Small Business
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Ex Transition Period
Entity Ex Transition Period
Entity Shell Company
Entity Shell Company
Entity File Number
Entity File Number
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address Address Line1
Entity Address Address Line2
Entity Address Address Line2
Entity Address, City or Town
Entity Address City Or Town
Entity Address, State or Province
Entity Address State Or Province
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Title of 12(b) Security
Security12b Title
Security Exchange Name
Security Exchange Name
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Entity Interactive Data Current
Entity Interactive Data Current
Document Annual Report
Document Annual Report
Document Transition Report
Document Transition Report
Entity Well-known Seasoned Issuer
Entity Well Known Seasoned Issuer
Entity Voluntary Filers
Entity Voluntary Filers
ICFR Auditor Attestation Flag
Icfr Auditor Attestation Flag
Entity Public Float
Entity Public Float
Auditor Name
Auditor Name
Auditor Location
Auditor Location
Auditor Firm ID
Auditor Firm Id
Build-to-suit lease liability.
Statement Of Financial Position [Abstract]
ASSETS
Assets [Abstract]
Current assets:
Assets Current [Abstract]
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Prepaid expenses and other current assets
Prepaid Expense And Other Assets Current
Total current assets
Assets Current
Restricted cash
Restricted Cash
Deferred lease asset
Deferred Costs Leasing Net Noncurrent
Property, plant and equipment, net
Property Plant And Equipment Net
Other non-current assets
Other Assets Noncurrent
Total assets
Assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities And Stockholders Equity [Abstract]
Current liabilities
Liabilities Current [Abstract]
Accounts payable
Accounts Payable Current
Accrued expenses and other current liabilities
Accrued Liabilities And Other Liabilities
Total current liabilities
Liabilities Current
Build-to-suit lease liability
Build To Suit Lease Liability
Term loan, net
Long Term Debt Noncurrent
Other non-current liabilities
Other Liabilities Noncurrent
Total liabilities
Liabilities
Stockholders' equity
Stockholders Equity [Abstract]
Preferred stock, $0.00001 par value per share; 10,000,000 shares authorized and no shares issued and outstanding as of December 31, 2021 and December 31, 2020
Preferred Stock Value
Common stock, $0.00001 par value per share; 200,000,000 shares authorized and 38,473,945 and 37,761,435 issued and outstanding as of December 31, 2021 and December 31, 2020
Common Stock Value
Additional paid-in capital
Additional Paid In Capital
Accumulated deficit
Retained Earnings Accumulated Deficit
Total stockholders’ equity
Stockholders Equity
Total liabilities and stockholders' equity
Liabilities And Stockholders Equity
Preferred stock, par value per share
Preferred Stock Par Or Stated Value Per Share
Preferred stock, shares authorized
Preferred Stock Shares Authorized
Preferred stock, shares issued
Preferred Stock Shares Issued
Preferred stock, shares outstanding
Preferred Stock Shares Outstanding
Common stock, par value per share
Common Stock Par Or Stated Value Per Share
Common stock, shares authorized
Common Stock Shares Authorized
Common stock, shares issued
Common Stock Shares Issued
Common stock, shares outstanding
Common Stock Shares Outstanding
Change in fair value preferred stock tranche liability.
Income Statement [Abstract]
Operating expenses:
Operating Expenses [Abstract]
Research and development
Research And Development Expense
General and administrative
General And Administrative Expense
Total operating expenses
Operating Expenses
Loss from operations
Operating Income Loss
Other income (expense):
Nonoperating Income Expense [Abstract]
Change in fair value of preferred stock tranche liability
Change In Fair Value Of Preferred Stock Tranche Liability
Interest income
Interest Income Expense Nonoperating Net
Interest expense
Interest Expense
Total other expense, net
Nonoperating Income Expense
Net loss
Net Income Loss
Net loss per common share, basic and diluted
Earnings Per Share Basic And Diluted
Weighted average common shares outstanding, basic and diluted
Weighted Average Number Of Share Outstanding Basic And Diluted
Temporary equity stock issued during period shares new issues.
Reclassification of Temporary Equity preferred stock tranche liability upon issuance of milestone shares.
Temporary equity conversion shares of convertible preferred stock to common stock.
Temporary equity conversion value of convertible preferred stock to common stock.
Issuance of common stock upon vesting and settlement of restricted stock units value.
Statement Of Stockholders Equity [Abstract]
Statement [Table]
Statement [Table]
Equity Components
Statement Equity Components [Axis]
Equity Component
Equity Component [Domain]
Common Stock
Common Stock [Member]
Additional Paid-in Capital
Additional Paid In Capital [Member]
Accumulated Deficit
Retained Earnings [Member]
Class of Stock
Statement Class Of Stock [Axis]
Class of Stock
Class Of Stock [Domain]
Series A Convertible preferred stock.
Series A Convertible Preferred Stock
Series A Convertible Preferred Stock [Member]
Series B convertible preferred stock.
Series B Convertible Preferred Stock
Series B Convertible Preferred Stock [Member]
Statement [Line Items]
Statement [Line Items]
Balance
Balance, shares
Issuance of convertible preferred stock
Temporary Equity Stock Issued During Period Value New Issues
Issuance of convertible preferred stock, shares
Temporary Equity Stock Issued During Period Shares New Issues
Reclassification of preferred stock tranche liability upon issuance of Series A milestone shares
Reclassification Of Temporary Equity Preferred Stock Tranche Liability Upon Issuance Of Milestone Shares
Conversion of Series A and Series B convertible preferred stock to common stock
Temporary Equity Conversion Value Of Convertible Preferred Stock To Common Stock
Conversion of Series A and Series B convertible preferred stock to common stock, shares
Temporary Equity Conversion Shares Of Convertible Preferred Stock To Common Stock
Conversion of Series A and Series B convertible preferred stock to common stock
Stock Issued During Period Value Conversion Of Convertible Securities
Conversion of convertible to common stock, shares
Stock Issued During Period Shares Conversion Of Convertible Securities
Issuance of restricted stock award
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
Issuance of restricted stock award, shares
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
Stock-based compensation
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Issuance of shares of common stock
Stock Issued During Period Value New Issues
Issuance of shares of common stock, shares
Stock Issued During Period Shares New Issues
Issuance of common stock, upon vesting and settlement of restricted stock units
Issuance Of Common Stock Upon Vesting And Settlement Of Restricted Stock Units Value
Net loss
Balance
Convertible preferred stock balance, shares
Temporary Equity Shares Outstanding
Convertible preferred stock balance
Temporary Equity Carrying Amount Attributable To Parent
Balance, shares
Temporary equity stock offering costs.
Temporary equity stock issuance of preferred stock tranche liability.
Issuance of convertible preferred stock, offering costs
Temporary Equity Stock Offering Costs
Issuance of shares of common stock in initial public offering, net of offering costs and underwriting discounts and commissions
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
Issuance of preferred stock tranche liability
Temporary Equity Stock Issuance Of Preferred Stock Tranche Liability
Increase decrease in accrued expense and other liabilities.
Proceeds from term loan, net.
Payment of shelf registration costs.
Property and equipment in accounts payable and accrued expenses.
Reclassification of preferred stock liability.
Allocation of preferred stock tranche liability.
Conversion of convertible preferred stock to common stock.
Research and development license not yet paid.
Statement Of Cash Flows [Abstract]
Cash flows from operating activities
Net Cash Provided By Used In Operating Activities [Abstract]
Net loss
Profit Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Depreciation expense
Depreciation
Change in fair value of preferred stock tranche liability
Research and development license expense
Research And Development In Process
Stock-based compensation
Share Based Compensation
Other
Other Noncash Income Expense
Changes in operating assets and liabilities:
Increase Decrease In Operating Capital [Abstract]
Prepaid expenses and other assets
Increase Decrease In Prepaid Deferred Expense And Other Assets
Accounts payable
Increase Decrease In Accounts Payable
Accrued expenses and other liabilities
Increase Decrease In Accrued Expense And Other Liabilities
Due to related party
Increase Decrease In Due To Related Parties
Net cash used in operating activities
Net Cash Provided By Used In Operating Activities
Cash flows from investing activities
Net Cash Provided By Used In Investing Activities [Abstract]
Purchase of research and development license
Payments To Acquire In Process Research And Development
Purchase of property, plant and equipment
Payments To Acquire Property Plant And Equipment
Net cash used in investing activities
Net Cash Provided By Used In Investing Activities
Cash flows from financing activities
Net Cash Provided By Used In Financing Activities [Abstract]
Proceeds from Term Loan, net
Proceeds From Term Loan Net
Proceeds from initial public offering, net of underwriting discounts and commission and other offering costs
Proceeds From Issuance Initial Public Offering
Payment of shelf registration costs
Payment Of Shelf Registration Costs
Other
Proceeds From Payments For Other Financing Activities
Proceeds from convertible preferred stock, net of issuance costs
Proceeds From Issuance Of Convertible Preferred Stock
Proceeds from note payable to related party
Proceeds From Related Party Debt
Repayment of note payable to related party
Repayments Of Related Party Debt
Net cash provided by financing activities
Net Cash Provided By Used In Financing Activities
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Cash, cash equivalents and restricted cash at the beginning of the period
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
Cash, cash equivalents and restricted cash at the end of the period
Supplemental disclosure of cash flow information:
Supplemental Cash Flow Information [Abstract]
Cash paid for interest
Interest Paid Net
Supplemental disclosure of noncash investing and financing activities:
Noncash Investing And Financing Items [Abstract]
Property, plant and equipment in accounts payable and accrued expenses
Property And Equipment In Accounts Payable And Accrued Expenses
Acquisition of property, plant and equipment funded by landlord
Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
Build-to-suit lease liability
Capital Lease Obligations Incurred
Deferred offering costs not yet paid
Capital Expenditures Incurred But Not Yet Paid
Reclassification of preferred stock tranche liability
Reclassification Of Preferred Stock Liability
Allocation of preferred stock tranche liability
Allocation Of Preferred Stock Tranche Liability
Conversion of Series A and Series B convertible preferred stock to common stock
Conversion Of Convertible Preferred Stock To Common Stock
Purchase of research and development license not yet paid
Research And Development License Not Yet Paid
Documents Incorporated by Reference
Documents Incorporated By Reference [Text Block]
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization and Description of Business Operations
Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]
Accounting Policies [Abstract]
Significant Accounting Policies
Significant Accounting Policies [Text Block]
Balance Sheet Related Disclosures [Abstract]
Supplemental Financial Information
Supplemental Balance Sheet Disclosures [Text Block]
Debt Disclosure [Abstract]
Loan with Silicon Valley Bank
Debt Disclosure [Text Block]
Research, collaboration and license agreements.
Research Collaboration And License Agreements [Abstract]
Research, Collaboration, Grant and License Agreements
Collaborative Arrangement Disclosure [Text Block]
Related Party Transactions [Abstract]
Related Party Transactions
Related Party Transactions Disclosure [Text Block]
Equity [Abstract]
Stockholders' Equity (Deficit), Convertible Preferred Stock and Tranche Liability
Stockholders Equity Note Disclosure [Text Block]
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
Earnings Per Share [Abstract]
Net Loss Per Common Share
Earnings Per Share [Text Block]
Income Tax Disclosure [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies
Commitments And Contingencies Disclosure [Text Block]
Compensation And Retirement Disclosure [Abstract]
Retirement Plan
Pension And Other Postretirement Benefits Disclosure [Text Block]
Subsequent Events [Abstract]
Subsequent Events
Subsequent Events [Text Block]
Property Plant and Equipment, net
Property Plant And Equipment Policy [Text Block]
Build-to-suit lease.
Build-to-Suit Lease
Build To Suit Lease Policy [Text Block]
Basis of Presentation
Basis Of Accounting Policy Policy [Text Block]
Principles of Consolidation
Consolidation Policy [Text Block]
Emerging growth company.
Emerging Growth Company
Emerging Growth Company Policy [Text Block]
Use of Estimates
Use Of Estimates
Risks and uncertainties.
Risks and Uncertainties
Risks And Uncertainties Policy [Text Block]
Segments
Segment Reporting Policy Policy [Text Block]
Cash and Cash Equivalents
Cash And Cash Equivalents Policy [Text Block]
Restricted Cash
Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy
Concentrations of Credit Risk
Concentration Risk Credit Risk
Fair Value of Financial Instruments
Fair Value Of Financial Instruments Policy
Deferred Offering Costs
Deferred Charges Policy [Text Block]
Impairment of Long-Lived Assets
Impairment Or Disposal Of Long Lived Assets Policy [Text Block]
Debt Issuance Costs
Debt Policy [Text Block]
Convertible preferred stock.
Convertible Preferred Stock
Convertible Preferred Stock Policy [Text Block]
Preferred stock tranche liability.
Preferred Stock Tranche Liability
Preferred Stock Tranche Liability Policy [Text Block]
Research and Development
Research And Development Expense Policy
Stock-Based Compensation
Compensation Related Costs Policy [Text Block]
Income Taxes
Income Tax Policy [Text Block]
Comprehensive Loss
Comprehensive Income Policy Policy [Text Block]
Recently Adopted Accounting Pronouncements
New Accounting Pronouncements Policy Policy [Text Block]
Recently issued accounting pronouncements policy.
Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements Policy Policy [Text Block]
Schedule of Property, Plant and Equipment
Property Plant And Equipment [Text Block]
Schedule of accrued expense and other current labilities.
Schedule of Accrued Expenses and Other Current Labilities
Schedule Of Accrued Expense And Other Current Labilities Table [Text Block]
Schedule of Prepaid Expenses and Other Current Assets
Deferred Costs Capitalized Prepaid And Other Assets Disclosure [Text Block]
Schedule of Future Principal Debt Payments on Term Loan Agreement
Schedule Of Maturities Of Long Term Debt Table [Text Block]
Reconciliation of preferred stock tranche liability measured at fair value.
Reconciliation of Preferred Stock Tranche Liability Measured at Fair Value
Reconciliation Of Preferred Stock Tranche Liability Measured At Fair Value Table [Text Block]
Award Type
Award Type [Axis]
Award Type
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Cancelled options.
Cancelled Options
Cancelled Options [Member]
Stock Options
Employee Stock Option [Member]
Schedule of Assumptions Used to Estimate Fair Value of Stock Options and Cancelled Options
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Schedule of Stock Option Activity
Schedule Of Share Based Compensation Activity Table [Text Block]
Schedule of Restricted Stock Units Activity
Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block]
Schedule of Restricted Stock Awards Activity
Nonvested Restricted Stock Shares Activity Table [Text Block]
Schedule of Total Remaining Stock-Based Compensation Expense for Stock Options, RSAs and RSUs (Detail)
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]
Schedule of Calculation of Basic and Diluted Net Loss Per Common Share
Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]
Schedule of Common Stock Equivalents Outstanding Excluded from Computation of Diluted Net Loss Per Share Attributable to Common Stockholders
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Schedule of Reconciliation of Federal Statutory Income Tax Rate
Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]
Schedule of Significant Components of Net Deferred Tax Asset
Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]
Schedule of Aggregate Lease Commitments
Lessee Operating Lease Liability Maturity Table [Text Block]
Organization and description of business operations.
Organization and description of business operations.
Organization And Description Of Business Operations [Table]
Organization And Description Of Business Operations [Table]
Sale of Stock
Subsidiary Sale Of Stock [Axis]
Sale of Stock
Sale Of Stock Name Of Transaction [Domain]
IPO
I P O [Member]
Underwriters’ Option to Purchase Additional Shares
Over Allotment Option [Member]
Collaborative Arrangement and Arrangement Other than Collaborative
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Arrangements And Nonarrangement Transactions [Member]
Sales Agreement.
Sales Agreement
Sales Agreement [Member]
Product and Service
Product Or Service [Axis]
Product and Service
Products And Services [Domain]
Sales agent.
Sales Agents
Sales Agent [Member]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Maximum
Maximum [Member]
Minimum [Member]
Minimum [Member]
Organization and Description of Business Operations [Line Items]
Organization And Description Of Business Operations [Line Items]
Date of incorporation
Entity Incorporation Date Of Incorporation
Conversion ratio
Stockholders Equity Note Stock Split Conversion Ratio1
Share issue price per share
Shares Issued Price Per Share
Net proceeds from issuance of common stock
Proceeds From Issuance Of Common Stock
Conversion of convertible preferred stock to common stock, shares
Common stock increase in outstanding shares.
Increase in outstanding shares
Common Stock Increase In Outstanding Shares
Aggregate offering price from sale of common stock.
Percentage of sale price per share of common stock.
Common stock shares issued and sold.
Aggregate offering price from sale of common stock
Aggregate Offering Price From Sale Of Common Stock
Percentage of gross sales price per share of common stock
Percentage Of Sale Price Per Share Of Common Stock
Common stock shares issued and sold
Common Stock Shares Issued And Sold
Accumulated deficit
Aggregate shares sold
Sale Of Stock Number Of Shares Issued In Transaction
Proceeds from issuances of convertible preferred stock, net of issuance costs
Significant accounting policies line items.
Significant accounting policies table.
Significant Accounting Policies [Table]
Significant Accounting Policies [Table]
Geographical
Statement Geographical [Axis]
Geographical
Segment Geographical [Domain]
United States
UNITED STATES
Balance Sheet Location
Balance Sheet Location [Axis]
Balance Sheet Location
Balance Sheet Location [Domain]
Prepaid Expenses and Other Current Assets
Prepaid Expenses And Other Current Assets [Member]
Minimum
Accounting Standards Update
Adjustments For New Accounting Pronouncements [Axis]
Accounting Standards Update
Type Of Adoption [Member]
ASU 2018-13
Accounting Standards Update201813 [Member]
ASU No. 2018-18
Accounting Standards Update201818 [Member]
Significant Accounting Policies [Line Items]
Significant Accounting Policies [Line Items]
Long-lived assets
Noncurrent Assets
Cash equivalents
Cash Equivalents At Carrying Value
Shelf registration,term
Shelf Registration,term
Shelf Registration Term
Deferred offering costs
Deferred Offering Costs
Property and equipment, useful life
Property Plant And Equipment Useful Life
Impairment losses
Impairment Of Long Lived Assets Held For Use
Increase in the amount of gross unrecognized tax benefits
Unrecognized Tax Benefits Period Increase Decrease
Unrecognized tax benefits to change significantly over next 12 months
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
Interest and penalties associated with income tax positions
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
Change in Accounting Principle, Accounting Standards Update, Adopted [true false]
Change In Accounting Principle Accounting Standards Update Adopted
Change in Accounting Principle, Accounting Standards Update, Adoption Date
Change In Accounting Principle Accounting Standards Update Adoption Date
Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]
Change In Accounting Principle Accounting Standards Update Immaterial Effect
Change in Accounting Principle, Accounting Standards Update, Early Adoption [true false]
Change In Accounting Principle Accounting Standards Update Early Adoption
Schedule Of Property Plant And Equipment [Table]
Schedule Of Property Plant And Equipment [Table]
Long-Lived Tangible Asset
Property Plant And Equipment By Type [Axis]
Long-Lived Tangible Asset
Property Plant And Equipment Type [Domain]
Leasehold Improvements
Leasehold Improvements [Member]
Furniture and Fixtures
Furniture And Fixtures [Member]
Computer Equipment
Computer Equipment [Member]
Construction in Progress
Construction In Progress [Member]
Laboratory equipment.
Laboratory Equipment
Laboratory Equipment [Member]
Property, Plant and Equipment [Line Items]
Property Plant And Equipment [Line Items]
Property and equipment, gross
Property Plant And Equipment Gross
Accumulated depreciation
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Property, plant and equipment, net
Build-to-suit lease.
Build-to-Suit Lease
Build To Suit Lease [Member]
Payroll and payroll-related costs.
Payroll and Payroll Related Costs
Payroll And Payroll Related Costs [Member]
Construction in progress
Construction In Progress Gross
Accrued research and development current.
Accrued license fees current.
Accrued property, plant, and equipment current.
Accrued clinical trials current.
Accrued research and development
Accrued Research And Development Current
Accrued compensation
Employee Related Liabilities Current
Accrued license fees
Accrued License Fees Current
Accrued property, plant, and equipment
Accrued Property Plant And Equipment Current
Accrued clinical trials
Accrued Clinical Trials Current
Accrued professional and consulting fees
Accrued Professional Fees Current
Other
Other Liabilities Current
Total accrued expenses and other current liabilities
Prepaid research and development contracts.
Prepaid clinical trial.
Prepaid bonus.
Prepaid research and development
Prepaid Research And Development Contracts
Prepaid clinical trial
Prepaid Clinical Trial
Prepaid bonus
Prepaid Bonus
Prepaid insurance
Prepaid Insurance
Other
Other Assets Current
Total prepaid expenses and other current assets
Number of distinct and active clinical stage.
Debt Instrument [Table]
Debt Instrument [Table]
Debt Instrument
Debt Instrument [Axis]
Debt Instrument, Name
Debt Instrument Name [Domain]
Term loan through december thirty one twenty twenty one.
Through December 31, 2021
Term Loan Through December Thirty One Twenty Twenty One [Member]
Term loan from january one twenty twenty two until september thirty twenty twenty two.
January 1, 2022 until September 30, 2022
Term Loan From January One Twenty Twenty Two Until September Thirty Twenty Twenty Two [Member]
Term loan from october one twenty twenty two until march thirty one twenty twenty three.
October 1, 2022 until March 31, 2023
Term Loan From October One Twenty Twenty Two Until March Thirty One Twenty Twenty Three [Member]
Term loan from april one twenty twenty three until december thirty one twenty twenty three.
April 1, 2023 until December 31, 2023
Term Loan From April One Twenty Twenty Three Until December Thirty One Twenty Twenty Three [Member]
Long-term Debt, Type
Longterm Debt Type [Axis]
Long-term Debt, Type
Longterm Debt Type [Domain]
Term loan facility.
Term Loan
Term Loan Facility [Member]
Variable Rate
Variable Rate [Axis]
Variable Rate
Variable Rate [Domain]
Prime Rate
Prime Rate [Member]
Term loan through august thirteen twenty twenty two.
Through August 13, 2022
Term Loan Through August Thirteen Twenty Twenty Two [Member]
Term loan through august thirteen twenty twenty three.
Through August 13, 2023
Term Loan Through August Thirteen Twenty Twenty Three [Member]
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Maximum borrowing capacity
Line Of Credit Facility Maximum Borrowing Capacity
Debt instrument, maturity date
Debt Instrument Maturity Date
Debt instrument, maturity start date
Debt Instrument Maturity Date Range Start1
Debt instrument, maturity end date
Debt Instrument Maturity Date Range End1
Number of distinct and active clinical stage
Number Of Distinct And Active Clinical Stage
Current borrowing capacity
Line Of Credit Facility Current Borrowing Capacity
Percentage of interest rate
Debt Instrument Interest Rate Stated Percentage
Debt instrument, basis spread on variable rate
Debt Instrument Basis Spread On Variable Rate1
Percentage of prepayment premium
Percentage of prepayment of facility.
Percentage of prepayment premium
Percentage Of Prepayment Premium
Percentage of prepayment of facility
Percentage Of Prepayment Of Facility
Warrants associated with loan facility
Warrants And Rights Outstanding
Exit fee recorded as debt discount
Debt Instrument Unamortized Discount Noncurrent
Percentage of annual default interest rate.
Percentage of annual default interest rate
Percentage Of Annual Default Interest Rate
Interest expense related to term loan
Interest Expense Long Term Debt
2022
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
2023
Long Term Debt Maturities Repayments Of Principal In Year Two
2024
Long Term Debt Maturities Repayments Of Principal In Year Three
2025
Long Term Debt Maturities Repayments Of Principal In Year Four
2026
Long Term Debt Maturities Repayments Of Principal In Year Five
Total principal payments
Debt Instrument Carrying Amount
Unamortized debt discount
Debt Instrument Unamortized Discount
Term Loan, net
Long Term Debt
Preclinical activities period under sponsored research agreements.
Minimum licensed product to develop obtain regulatory approval for and commercialize.
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Counterparty Name
Counterparty Name [Axis]
Counterparty Name
Repurchase Agreement Counterparty Name [Domain]
UT southwestern agreement.
UT Southwestern Agreement
U T Southwestern Agreement [Member]
Queen's agreement.
Queen's Agreement
Queens Agreement [Member]
Income Statement Location
Income Statement Location [Axis]
Income Statement Location
Income Statement Location [Domain]
Research and Development Expense
Research And Development Expense [Member]
Abeona CLN1 agreements.
Abeona CLN1 Agreements
Abeona C L N1 Agreements [Member]
Abeona Rett agreement.
Abeona Rett Agreement
Abeona Rett Agreement [Member]
Abeona Therapeutics Inc.
Abeona
Abeona Therapeutics Inc [Member]
Acquisition of worldwide rights for TSHA 120 for treatment of giant axonal neuropathy.
TSHA-120
Acquisition Of Worldwide Rights For T S H A120 For Treatment Of Giant Axonal Neuropathy [Member]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Preclinical activities period under sponsored research agreements
Preclinical Activities Period Under Sponsored Research Agreements
Minimum licensed product to develop obtain regulatory approval for and commercialize
Minimum Licensed Product To Develop Obtain Regulatory Approval For And Commercialize
Percentage of fully diluted common stock shares outstanding.
Percentage of common stock shares entitled to receive additional shares on fully diluted basis.
Percentage of fully diluted common stock shares outstanding
Percentage Of Fully Diluted Common Stock Shares Outstanding
Percentage of entitled to receive additional shares on fully diluted basis
Percentage Of Common Stock Shares Entitled To Receive Additional Shares On Fully Diluted Basis
Research grant of committed fund amount.
Research grant of committed fund amount
Research Grant Of Committed Fund Amount
Payments to acquire license right.
License agreement regulatory milestones payment.
License agreement commercial milestones payment.
Additional Milestone payments.
Cash payment to acquire license agreement
Payments To Acquire License Right
License agreement regulatory milestones payment
License Agreement Regulatory Milestones Payment
License agreement commercial milestones payment
License Agreement Commercial Milestones Payment
Additional milestone payments
Additional Milestone Payments
Payment of license fee.
Purchase of clinical materials and reimbursement incurred development costs.
License and inventory purchase agreement regulatory related milestones payment.
License and inventory purchase agreement sales related milestones payment.
License fee payment
Payment Of License Fee
Purchase of clinical materials and reimbursement incurred development costs
Purchase Of Clinical Materials And Reimbursement Incurred Development Costs
License and inventory purchase agreement regulatory related milestones payment
License And Inventory Purchase Agreement Regulatory Related Milestones Payment
License and inventory purchase agreement sales related milestones payment
License And Inventory Purchase Agreement Sales Related Milestones Payment
Regulatory related milestones obligation payable.
Sale-related milestones per licensed product and royalties on net sales of licensed products payable.
Payment of one-time upfront license fee.
Payment of one-time upfront license fee
Payment Of One Time Upfront License Fee
Regulatory related milestones obligation payable
Regulatory Related Milestones Obligation Payable
Sale-related milestones per licensed product and royalties on net sales of licensed products payable
Sale Related Milestones Per Licensed Product And Royalties On Net Sales Of Licensed Products Payable
Upfront payment.
Clinical, regulatory and commercial milestones to be received.
Upfront payment
Upfront Payment
Clinical, regulatory and commercial milestones to be received
Clinical Regulatory And Commercial Milestones To Be Received
Number of secured promissory notes.
Schedule Of Related Party Transactions By Related Party [Table]
Schedule Of Related Party Transactions By Related Party [Table]
Secured promissory notes.
Secured Promissory Notes
Secured Promissory Notes [Member]
Title of Individual
Title Of Individual [Axis]
Title of Individual
Title Of Individual With Relationship To Entity [Domain]
President and chief executive officer.
RA Session II
President And Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Number of secured promissory notes
Number Of Secured Promissory Notes
Aggregate amount, related party transaction
Debt Instrument Face Amount
Interest expense related party
Interest Expense Related Party
Schedule Of Stock By Class [Table]
Schedule Of Stock By Class [Table]
IPO
Series A purchase agreement.
Series A Purchase Agreement
Series A Purchase Agreement [Member]
Series A purchase agreement initial closing.
Initial Closing
Series A Purchase Agreement Initial Closing [Member]
Series A achievement of specific clinical milestone one.
Achievement of Specific Clinical Milestone One
Series A Achievement Of Specific Clinical Milestone One [Member]
Series A achievement of specific clinical milestone two.
Achievement of Specific Clinical Milestone Two
Series A Achievement Of Specific Clinical Milestone Two [Member]
Series A upon achievement of certain defined clinical milestones.
Upon Achievement of Certain Defined Clinical Milestones
Series A Upon Achievement Of Certain Defined Clinical Milestones [Member]
Private Placement
Private Placement [Member]
PBM TGT holdings, limited liability company.
PBM TGT Holdings, LLC
P B M T G T Holdings Limited Liability Company [Member]
Nolan capital, limited liability company.
Nolan Capital, LLC
Nolan Capital Limited Liability Company [Member]
Series B purchase agreement.
Series B Purchase Agreement
Series B Purchase Agreement [Member]
Measurement Input Type
Measurement Input Type [Axis]
Measurement Input Type
Measurement Input Type [Domain]
Risk Free Rate
Measurement Input Risk Free Interest Rate [Member]
Expected Volatility
Measurement Input Price Volatility [Member]
Measurement input probability of achieving clinical milestones and timing.
Probability of Achieving Clinical Milestones and Timing
Measurement Input Probability Of Achieving Clinical Milestones And Timing [Member]
Class Of Stock [Line Items]
Class Of Stock [Line Items]
Common stock, shares authorized
Convertible preferred stock, shares authorized
Temporary Equity Shares Authorized
Convertible preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Proceeds from issuance of common stock, gross.
Shares issued during period
Gross proceeds from issuance of common stock
Proceeds From Issuance Of Common Stock Gross
Stock issuance costs, including underwriters' discounts and commissions
Payments Of Stock Issuance Costs
Conversion of convertible preferred stock to common stock, shares
Conversion of stock, shares issued
Number of share options exercised
Stock Issued During Period Shares Stock Options Exercised
Clinical milestones for gross proceeds
Proceeds From Collaborators
Proceeds from issuances of convertible preferred stock, net of issuance costs
Convertible preferred stock tranche liability offering price.
Convertible preferred stock tranche liability measurement input.
Convertible preferred stock tranche liability liquidity term.
Convertible preferred stock tranche liability, offering price
Convertible Preferred Stock Tranche Liability Offering Price
Convertible preferred stock tranche liability, measurement input
Convertible Preferred Stock Tranche Liability Measurement Input
Convertible preferred stock tranche liability, term
Convertible Preferred Stock Tranche Liability Liquidity Term
Preferred Stock Tranche Liability.
Preferred stock tranche liability
Preferred Stock Tranche Liability
Issuance of pro-rata portion of milestone shares.
Mile stone shares issued.
Amount reclassified to convertible preferred stock.
Milestone pro-rate shares issued during the period
Issuance Of Pro Rata Portion Of Milestone Shares
Non cash expenses due to remeasured fair value of tranche liability
Mile stone shares issued during the period
Mile Stone Shares Issued
Tranche liability amount reclassified to convertible preferred stock
Amount Reclassified To Convertible Preferred Stock
Fair Value Assets And Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Abstract]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Liability Class
Fair Value By Liability Class [Axis]
Fair Value by Liability Class
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]
Preferred stock tranche liability.
Preferred Stock Tranche Liability
Preferred Stock Tranche Liability [Member]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Balance at December 31, 2019
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
Fair value at issuance of Series A convertible preferred stock
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
Change in fair value
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
Settlement of preferred stock tranche liability due to issuance of Milestone Shares
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
Balance at December 31, 2020
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Plan Name
Plan Name [Axis]
Plan Name
Plan Name [Domain]
Two thousand twenty equity incentive plan.
2020 Equity Incentive Plan
Two Thousand Twenty Equity Incentive Plan [Member]
Two thousand twenty stock incentive plan.
New Plan
Two Thousand Twenty Stock Incentive Plan [Member]
Employee stock purchase plan.
Employee Stock Purchase Plan (ESPP)
Employee Stock Purchase Plan [Member]
Restricted Stock Units
Restricted Stock Units R S U [Member]
Certain employees and consultants.
Certain Employees and Consultants
Certain Employees And Consultants [Member]
Directors
Director [Member]
Vesting
Vesting [Axis]
Vesting
Vesting [Domain]
Share-based Payment Arrangement, Tranche One
Share Based Compensation Award Tranche One [Member]
Share-based Payment Arrangement, Tranche Two
Share Based Compensation Award Tranche Two [Member]
Share-based Payment Arrangement, Tranche Three
Share Based Compensation Award Tranche Three [Member]
Share based compensation award tranche four.
Share-based Payment Arrangement, Tranche Four
Share Based Compensation Award Tranche Four [Member]
Restricted Stock Awards
Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized for issuance
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
Share based compensation arrangement by share based payment award commencement date.
Percentage of automatic increase every year in common stock shares reserved for future issuance.
Common stock reserved for future issuance
Common Stock Capital Shares Reserved For Future Issuance
Share-based payment award, expiration period
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
Share-based payment award, commencement date
Share Based Compensation Arrangement By Share Based Payment Award Commencement Date
Share-based payment award, expiration date
Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
Percentage of automatic increase every year in common stock shares reserved for future issuance
Percentage Of Automatic Increase Every Year In Common Stock Shares Reserved For Future Issuance
Share-based payment award, terms of award issuance
Share Based Compensation Arrangement By Share Based Payment Award Terms Of Award
Number of shares of common stock issued under ESPP
Stock Issued During Period Shares Employee Stock Purchase Plans
Share based compensation arrangement by share based payment award options grants in period grant date fair value.
Share based compensation arrangement by share based payment award equity instruments other than options replacement units grants in period.
Share-based payment award, options granted
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Share-based payment award, options granted, exercise price per share
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Award vesting period
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
Share-based payment award, options grant date fair value
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value
Number of shares awarded
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Units Grants In Period
Share-based payment award, plan modification, incremental cost
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
Common stock fair value per share.
Fair value of common stock per share
Common Stock Fair Value Per Share
Preferred stock, issuing price per share
Share Price
Risk-free interest rate
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
Expected dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Expected term in years
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Expected volatility
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
Share-based payment award, options, weighted-average grant date fair value
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Outstanding. Stock Options, Beginning Balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Options granted, Stock Options
Options cancelled or forfeited, Stock Options
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Outstanding. Stock Options, Ending Balance
Options exercisable at December 31, 2021, Stock Options
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
Outstanding, Weighted Average Exercise Price, Beginning balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Options granted, Weighted Average Exercise Price
Options cancelled or forfeited, Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
Outstanding, Weighted Average Exercise Price, Ending balance
Options exercisable at December 31, 2021, Weighted Average Exercise Price
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
Outstanding, Weighted Average Remaining Contractual Life
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Weighted Average Remaining Contractual Life, Options exercisable at December 31, 2021
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
Share based compensation arrangement by share based payment award options grants in period intrinsic value.
Outstanding, Aggregate Intrinsic Value, Beginning Balance
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Options granted, Aggregate Intrinsic Value
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
Outstanding, Aggregate Intrinsic Value, Ending Balance
Options exercisable at December 31, 2021, Aggregate Intrinsic Value
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
Stock options were exercised during the period
Stock Issued During Period Value Stock Options Exercised
Share-based payment award, options, compensation cost not yet recognized
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Share-based payment award, compensation cost not yet recognized, weighted-average period of recognition
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Share-based payment award, RSU/RSA granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Share-based payment award, vesting rights percentage
Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
Share-based payment award, unvested RSU/RSA granted, compensation cost not yet recognized
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
Nonvested, Number of Shares, Beginning Balance
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
Replacement restricted units granted, Number of Shares
Restricted units/stock granted, Number of Shares
Vested, Number of Shares
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
Cancelled or forfeited, Number of Shares
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
Nonvested, Number of Shares, Ending Balance
Share based compensation arrangement by share based payment award equity instruments other than options replacement units grants in period weighted average grant date fair value.
Nonvested, Weighted Average Grant Date Fair Value per Share, Beginning Balance
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
Replacement restricted units granted, Weighted Average Grant Date Fair Value per Share
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Replacement Units Grants In Period Weighted Average Grant Date Fair Value
Restricted units/stock granted, Weighted Average Grant Date Fair Value per Share
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
Vested, Weighted Average Grant Date Fair Value per Share
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
Cancelled or forfeited, Weighted Average Grant Date Fair Value per Share
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
Nonvested, Weighted Average Grant Date Fair Value per Share, Ending Balance
Award requisite service vesting period
Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
Share-based payment award, RSU/RSA granted, weighted average grant date fair value
Stock-based compensation expense
Allocated Share Based Compensation Expense
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
General and Administrative Expense
General And Administrative Expense [Member]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Net loss
Net Income Loss Available To Common Stockholders Basic
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities, Name
Antidilutive Securities Name [Domain]
Unvested RSUs
Unvested RSAs
Stock Options
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from computation of diluted net loss per share
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Income tax disclosure.
Income tax disclosure.
Income Tax Disclosure [Table]
Income Tax Disclosure [Table]
Income Tax Authority
Income Tax Authority [Axis]
Income Tax Authority
Income Tax Authority [Domain]
Federal
Domestic Country [Member]
State
State And Local Jurisdiction [Member]
Income Tax Disclosure [Line Items]
Income Tax Disclosure [Line Items]
Provision for income taxes
Income Tax Expense Benefit
Net operating loss carryforward percentage.
Tax cuts and jobs act adjusted taxable income limitation percentage.
Net operating loss carryforward percentage
Net Operating Loss Carryforward Percentage
Tax Cuts and Jobs Act, adjusted taxable income limitation percentage
Tax Cuts And Jobs Act Adjusted Taxable Income Limitation Percentage
Effective income tax rate reconciliation other permanent differences.
Effective income tax rate reconciliation change in fair value of tranche liability.
Statutory rate
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
State tax
Effective Income Tax Rate Reconciliation State And Local Income Taxes
Research and development tax credits
Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
Other permanent differences
Effective Income Tax Rate Reconciliation Other Permanent Differences
Change in valuation allowance
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
Change in fair value of tranche liability
Effective Income Tax Rate Reconciliation Change In Fair Value Of Tranche Liability
Income tax provision (benefit)
Effective Income Tax Rate Continuing Operations
Components Of Deferred Tax Assets [Abstract]
Net operating loss carryforwards
Deferred Tax Assets Operating Loss Carryforwards
Tax credit carryforwards
Deferred Tax Assets Tax Credit Carryforwards
Accruals and reserves
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
Other
Deferred Tax Assets Tax Deferred Expense Other
Intangibles
Deferred Tax Assets Goodwill And Intangible Assets
Non-qualified stock options
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
Total deferred tax assets
Deferred Tax Assets Gross
Valuation allowance
Deferred Tax Assets Valuation Allowance
Deferred tax asset, net of allowance
Deferred Tax Assets Net
Deferred tax liabilities
Deferred Tax Liabilities
Valuation allowance increased
Valuation Allowance Deferred Tax Asset Change In Amount
Tax credit carryforward expiration or due date year.
Net operating loss carryforward
Operating Loss Carryforwards
Tax credit carryforward expiration or due date year
Tax Credit Carryforward Expiration Or Due Date Year
Loss Contingencies [Table]
Loss Contingencies [Table]
Durham lease.
Durham Lease
Durham Lease [Member]
Dallas lease.
Dallas Lease
Dallas Lease [Member]
Pegasus Park, LLC.
Pegasus Park L L C
Pegasus Park L L C [Member]
Dallas lease amendment.
Dallas Lease Amendment
Dallas Lease Amendment [Member]
On-site generation lease.
On Site Generation Lease
On Site Generation Lease [Member]
Central utilities building.
Central Utilities Building
Central Utilities Building [Member]
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Number of operating lease landlord square feet manufacturing facility
Property Subject To Or Available For Operating Lease Number Of Units
Operating lease commencement date
Operations Commenced Date1
Operating lease term of contract
Lessee Operating Lease Term Of Contract
Operating lease extend term of contract
Lessee Operating Lease Renewal Term
Amount required to place in escrow account
Escrow Deposit
Operating leases initial direct costs.
Operating leases initial direct costs
Operating Leases Initial Direct Costs
Build-to-suit asset.
Built-to-suit lease liability.
Equipment purchases and build-out of leased facility.
Build-to-suit asset
Build To Suit Asset
Build-to-suit lease liability
Built To Suit Lease Liability
Equipment purchases and build-out of leased Facility
Equipment Purchases And Build Out Of Leased Facility
Obligation for payment of initial base rent for office space.
Maximum estimated monthly base rent increase annually during term of lease.
Maximum construction allowance provided by landlord per rentable square foot.
Lease, option to extend description
Lessee Operating Lease Option To Extend
Lease, option to extend
Lessee Operating Lease Existence Of Option To Extend
Obligation for payment of initial base rent for office space
Obligation For Payment Of Initial Base Rent For Office Space
Maximum estimated monthly base rent increase annually during term of lease
Maximum Estimated Monthly Base Rent Increase Annually During Term Of Lease
Security deposit
Security Deposit
Maximum construction allowance provided by landlord per rentable square foot
Maximum Construction Allowance Provided By Landlord Per Rentable Square Foot
Future minimum lease payments
Lessee Operating Lease Liability Payments Due
Lease construction incentive
Lease Incentive Receivable
Obligation for payment of fees for leased equipment and monthly maintenance and fuel acquisition costs.
Advanced monthly prepayments.
Obligation for payment of fees for leased equipment and monthly maintenance and fuel acquisition costs
Obligation For Payment Of Fees For Leased Equipment And Monthly Maintenance And Fuel Acquisition Costs
Advanced monthly prepayment
Advanced Monthly Payments
2022
Lessee Operating Lease Liability Payments Due Next Twelve Months
2023
Lessee Operating Lease Liability Payments Due Year Two
2024
Lessee Operating Lease Liability Payments Due Year Three
2025
Lessee Operating Lease Liability Payments Due Year Four
2026
Lessee Operating Lease Liability Payments Due Year Five
Thereafter
Lessee Operating Lease Liability Payments Due After Year Five
Total Lease Commitments
Contribution to retirement savings plan
Defined Contribution Plan Employer Discretionary Contribution Amount
License agreement regulatory related milestones maximum amount payable.
License agreement sales-related milestones maximum amount payable.
Subsequent Event [Table]
Subsequent Event [Table]
Subsequent Event Type
Subsequent Event Type [Axis]
Subsequent Event Type
Subsequent Event Type [Domain]
Subsequent Event
Subsequent Event [Member]
License agreement for CLN7.
License Agreement for CLN7
License Agreement For C L N7 [Member]
Subsequent Event [Line Items]
Subsequent Event [Line Items]
License agreement regulatory related milestones maximum amount payable
License Agreement Regulatory Related Milestones Maximum Amount Payable
License agreement sales-related milestones maximum amount payable
License Agreement Sales Related Milestones Maximum Amount Payable
Percentage of headcount reduced
Restructuring And Related Cost Number Of Positions Eliminated Period Percent
Severance and termination-related costs
Severance Costs1
Options granted for purchase an aggregate share of common stock
Weighted-average exercise price